Coffin, College of Arts and Sciences, Washington State University, 14204 NE Salmon Creek Avenue, Vancouver, WA 98686-9600, USA e-mail: [email protected] This article was submitted to the journal Frontiers in Cellular Neuroscience
It's almost like a fighter who fights and then gets so out of shape again
Here's how they compare: Peptide Primary research area FDA status Advisory committee review BPC-157 Tissue repair, angiogenesis Not approved Yes (free base + acetate) TB-500 Actin regulation, cell migration Not approved Yes MOTS-c Mitochondrial metabolism Not approved Yes KPV Anti-inflammatory Not approved Yes GHK-Cu Copper-peptide skin/healing Not approved Not on 2026 agenda For a deeper comparison of BPC-157 and its most-researched counterpart, see our BPC-157 vs TB-500 research comparison
1, 10, 20 g/L), with males showing a more pronounced response
CJC-1295 GH elevation in humans (J Clin Endocrinol Metab, 2006)